In this review we have summarized some of the evidence to support the view that mast cells play a critical role in leukocyte recruitment to sites of infktmmation. Initially, data using a pharmacological tool, compound 48/80, which directly activates mast cells, is reviewed, demonstrating that this reagent can induce the multi-step recruitment of leukocytes (rolling, adhesiotr and emi~tionl to sites of inflammation. The adhesive mechanisms and pro-inflammatory mediators implicated in mast cell-induced leukocyte recruitment are discussed. Additionally, data are presented to implicate mast cells in delayed-type hypersensitivity reactions as they pertain to leukocyte recruitment. There is a growing body of evidence to suggest that mast cells also recruit leukocytes in IgE-indepandent leukocyte recruitment. Ischemia/reperfusion-and bacterial toxin-(Helicobacter pylori and Clostridium dificile) induced leukocyte recruitment is at least in part mast cell dependent. Future directions including preliminary work highlighting the role of nitric oxide as a modulator of mast cell function and subsequent leukocyte recruitment is also discussed.
The recruitment of leukocytes from the mainstream of blood to the extravascular space is a key feature of the inflammatory response. It has been well established that leukocyte infiltration is a multi-step mechanism ( Fig. 1 ) which requires that leukocytes moving at very high speeds in the mainstream of biood make initial contact with the endothelial cells lining the vessel wall and roll along the vessel at a greatly reduced velocity relative to flowing red blood cells [ 1, 2] . This initial leukocyte-endothelial cell interaction is termed leukocyte rolling and is entirely dependent upon the selectin family of adhesion molecules [3, 4] , L-selectin is constitutively expressed on the surface of leukocytes and appears to be essential for the ability of these cells to initiate rolling in the microcirculation. Two other selectins, P-selectin (induced in minutes) and Eselectin (3-6 h for maximal induction) expressed on activated em&helium also contribute significantly to the rolling event. When activated, the rolling leukocytes firmly adhere to the endothelium and ultimately emigrate out of the vasculature. This event is mediated by the integrins found on leukocytes and in the case of neutrophils the &-integrin (CD 11 /CD 18).
There are three important assumptions made when considering this scheme for leukocyte recruitment. First this is an interrelated cascade of events and therefore the rolling event is a necessary prerequisite to leukocyte adhesion and subsequent emigration. Secondly, the rolling, adhesion and emigration transpire primarily within the pastcapillary venules and very rarely do investigators observe leukocyte-endothelial cell interactions in other vessels. A final point that should be made is that histology has established the phenotype of adhering and emigrating cells as neutrophils in the early event (first 8 h) and monocytes and lymphocytes at later time points (longer than 8 h). Although it is tempting to conclude that the rolling cells follow the same time frame as the adhering and emigrating cells, to date it has been impossible to determine the phenotype of the rolling population(s) of leukocytes. . Leukocyte (in this example neutrophil) recruitment is a multi-step event that is initiated by the selectina and manifested as a rolling interaction. This event is a prerequisite to firm adhesion and emigration via the &-integrins. The expression and/or activation of these adhesion molecules occurs via pro-inflammatory mediators released from the local environment. The mast cell found in close apposition to the vessels is a likely source of these molecules.
Therefore, the rather vague term "leukocyte" will be used throughout this review.
To date, a tremendous amount of literature has been published on the adhesive mechanisms underlying leukocyte recruitment and the identity of a signal or multiple signals that are released directly from the injured site to initiate the multi-step recruitment. However, far less is known about the source of these mediators. Mast cells are found closely apposed to the vasculature in essentially all tissues and are exquisitely sensitive to very subtle changes in the surrounding milieu. Once activated, they are capable of releasing a myriad of inflammatory mediators and therefore are certainly candidates as a first-line detector system and initiator of the inflammatory response (Fig. 1) . Mast cells release preformed cytokines, histamine, serotonin as well as newly synthesized platelet-activating factor, leukotrienes and many other mediators (see reviews for detail . Noteworthy for example is the fact that mast cells prepackage TNFG in granules where it is readily available for release [9] . Table 1 summarizes some of the mast cell-derived mediators that could impact directly upon the vasculature to either express endothelial adhesion molecules, activate leukocytes and/or induce both events. In light of the tremendous interest in cytokines and other pro-inflammatory molecules in disease, it is somewhat surprising that more attention has not been focused on the role of mast cells as contributors to cardiovascular disease. Table 2 summarizes some stimuli that have been documented to activate mast cells (see reviews for more detail [5-81). Although to date mast cell activation has been associated with IgE activation, there is a growing body of evidence to suggest that mast cells are activated via oxidants, anaphylatoxins, neuropeptides and bacterial products and are also exquisitely sensitive to physical stress, temperature changes and other physical disturbances [7, 10] . Clearly, increased levels of oxidants, anaphylatoxins, bacterial toxins and neuropeptides in ischemia/reperfusion, sepsis and anaphylaxis may affect the activity state of mast cells and thereby mediate one of the key features of the pathology associated with cardiovascular disease: leukocyte adhesion to endothelium.
Mast cells recruit leukocytes
The fact that mast cells can indeed affect the vasculature to recruit circulating leukocytes to sites of inflammation has been known for many years. Initial work [I l] supporting the view that mast cell degranulation was sufficient to induce leukocyte infiltration made use of the mast cell degranulating agent, compound 48/80 (CMP 48/80). This agent, when injected into the skin of mice induced a rapid (i.e., within l-2 h) neutrophilic influx into skin. This was followed at 24 h by a mononuclear infiltrate suggesting that mast cell degranulation had the capacity to recruit at least two types of leukocytes. Injection of mast cell granules into mouse skin elicited a similar cellular infiltrate as CMP 48/80, suggesting albeit indirectly that CMP 48/80 was functioning to degranulate mast cells to recruit leukocytes.
Visualization of leukocyte migration out of the microvasculature using intravital microscopy (see Ref.
[ 121 for review) has further elucidated the actions of CMP 48/80 and revealed that mast cells can indeed contribute to the multi-step recruitment of leukocytes (rolling, adhesion and emigration) [13] . In addition to being able to visualize the multi-step recruitment of leukocytes, one can use an intravital stain (ruthenium red) that continuously detects the degree of mast cell activation throughout the experiment [ 13, 141 . IJsing this technique it has been demonstrated that CMP 48/80 caused rapid activation of mast ceils which preceded the induction of leukocyte-endothelial cell interactions by approx. 1.5 min [ 131. Stabilization of the mast cells with sodium cromoglycate or ketotifen reduced both mast cell activation and leukocyte recruitment. Finally, chronically depleting mast cells of their granules in vivo prevented the subsequent recruitment of leukocytes with CMP 48/80. These data as a whole strongly support the view that CMP 48/80-induced leukocyte recruitment i5 mast cell dependent.
Mast ~11s mediute leukocyte rolling
Applying intravital microscopy to the rat mesentery, we [ 131 and others [ 15- 171 assessed whether mast cells could contribute to both the initial rolling movement along the length of the vessel wall and subsequent firm adhesion. Superfusion of the rat mesentery with CMP 48/80 revealed a rapid increase in the number of rolling leukocytes (relative to untreated preparations) that persisted for the next 60 min. The selectin responsible for the initial rapid rolling event along the length of vessels [ 1.21 is P-selectin, mobilized to the endothelial plasma membrane from Weibel-Palade bodies. P-Selectin supports leukocyte adhesion to monolayers of endothelium in static assay systems [ 181 and leukocyte rolling under shear conditions on Pselectin-containing artificial membranes [ 191. In vivo data also support a role for P-selectin in the induction of leukocyte rolling inasmuch as exogenously administered superoxide initiated leukocyte rolling, an event entirely inhibited by a P-selectin antibody 1201. The degranulation of perivascular mast cells was also sufficient to invoke leukocyte rolling [ 13, 171 , and the P-selectin MAb, PB 1.3, completely inhibited this event, supporting the view that substances released from mast cells were capable of inducing endothelial P-selectin-associated leukocyte rolling.
P-selectin can be mobilized to the endothelial cell surface by many different pro-inflammatory mediators including histamine, LTC,, thrombin and oxidants [ 18,2 l-241. In our laboratory the CMP 48/80-induced leukocyte rolling appeared to be histamine dependent inasmuch as diphenhydramine (H ,-receptor antagonist) inhibited the mast celldependent leukocyte rolling [13] . However. Thorlacius et al. [ 171 reported that the CMP 48/80-induced, selectin-dependent leukocyte rolling was not inhibitable by a different HI -receptor antagonist (mepyramine), in combination with an HZ-receptor antagonist (cimetidinel. This discrepancy remains unresolved: however, a recent study has demonstrated that mast cell-dependent leukocyte recruitment was inhibitable with a third H ,-receptor antagonist (hydroxyzinc) in a Chstridium di&iciZe toxin A model of inflammation (discussed later). Whether mepyramine has a lowet efficacy than the other H ,-receptor antagonists in the rat vasculature remains unknown. Inhibitors of' other mediators w:ere unremarkable in their ability to prevent the rise in mast cell-induced leukocyte rolling: inhibitors of leukotrienes, PAF or serotonin did not reduce the increased leukocyte rolling [ 13.253 .
Further evidence to demonstrate that mast cells could induce leukocyte recruitment was based on the observation that immediately upon exteriorization of tis5uc for intravital microscopy. there was a mast cell-dependent induction of leukocyte rolling [21] . Sodium cromoglycate. a potent inhibitor of histamine release from rat connective tissue mast cells [26] . given prior to surgical manipulation (but not after) attenuated by 80% baseline leukocyte rolling [2 11 . Moreover, diphenhydramine. the H ,-receptor antagonist. also significantly ( > .50%'0) reduced baseline leukocyte rolling. These data collectively suggested that mast cell-derived histamine (and other unidentified agents), promoted leukocyte rolling during surgical manipulation. The con cept of surgically induced rolling is consistent with the observations that leukocyte rolling is very low in normal tissues including the intact bat wing ]27] arid that leukocyte rolling increases rapidly at the time tot surgery [2X]. Moreover, the fact that baseline roliing could be prevented by immunoneutralizing P-selectin [29] with %elective antibodies or inhibiting both L-selectin and P-selectin with fucose polymers such as fucoidin [30] raises the possibility that the preparation-induced mast ceil activation potentially leads to P-selectin expression and increased baseline rolling. The proximity of mast cells to the vasculature [16.31] in conjunction with their intense sensitivity to physical stress, temperature changes and other physical disturbances that are likely to occur during surgical preparation [7, 10 ] make mast cells a good candidate to mediate baseline alterations in leukocyte-endothelinl cell interactiona.
Animals pretreated with cromolyn (must cell-stabilized preparations) were sensitive to histamme and responded to this amine with prolonged leukocyte rolling that was entirely inhibitable by either diphenhydramine or a P-selectin antibody [2 I] . In animals that had not been mast ccll-stabilized, there was little response to histamine It wa5 hypothesized that histamine released from m;t~r cells during surgical manipulation caused the vasculaturc to be tachyphylactic to subsequent histamine treatment. Very similar data were simultaneously published 1)~ +I\+iho et al. (321. who circumvented the problem of surgically induced mast cell degranulation by choosing those vessels wherein initial baseline leukocyte rolling was extremely low. Animals with a higher leukocyte rolling again failed to respond to histamine. Collectively, these data are consistent with the view that rat connective tissue mast cells are capable of recruiting rolling leukocytes via histamine. The mast cellstabilized preparation revealed that other mediators including LTC, [33] and H,O, [34] but not PAF [21] or serotonin [25] induced leukocyte rolling in vivo. It should be noted that it was impossible to use the mast cell-stabilized model to study (CMP 48/80-induced) mast cell-induced leukocyte rolling and therefore the increase in CMP 48/80-induced leukocyte rolling was relatively subtle in magnitude, but significant when compared to untreated control animals [ 131.
Mast cells cause leukocyte adhesion
The second step in the inflammatory cascade is firm adhesion of leukocytes to the venular endothelium, a mechanism dependent on the expression of the &integrin also termed CD1 l/CD18 [35, 36] . CMP 48/80-induced mast cell degranulation elicited a significant increase in leukocyte adhesion (Fig. 2a) . This adhesion was significantly attenuated by CL26, a monoclonal antibody to CD18, as well as by the aforementioned reagents that prevent leukocyte rolling (P-selectin antibody and diphenhydramine) [ 13, 171 , observations consistent with the concept that rolling is a necessary prerequisite for adhesion. CL26 had no effect on the flux of rolling leukocytes, suggesting that unlike adhesion which was entirely dependent on the recruitment of rolling leukocytes, leukocyte rolling occurred independently of CD18 and the adhesive process. Fig. 2b demonstrates that adhesion of leukocytes to endothelium could also be induced by degranulating mast cells in vitro. Addition of CMP 48/80 alone or mast cells alone to a monolayer of endothelium or protein-coated plastic did not promote neutrophil adhesion to either substratum. However, co-administration of CMP 48/80 and mast cells induced neutrophil adhesion to both endothelium and protein-coated wells. The adhesion was entirely inhibited by anti-CD18 antibody. These in vitro data address two important issues: (1) CMP 48/80 does not induce neutrophil-endothelial cell interactions directly (requires mast cells) and (2) the endothelium is not necessary for this adhesion as neutrophils can still be induced to adhere via mast cells to protein-coated plastic.
CD1 l/CD18 is constitutively expressed on the surface of leukocytes in an inactive state but can be rapidly activated in the presence of various chemotactic stimuli including PAF and LTB, to induce and support adhesion [35, 36] . It appears that synthesis of leukotrienes is not critical to the induction of leukocyte adhesion observed with mast cell degranulation inasmuch as MK886, which blocks membrane translocation of Slipoxygenase and sub- sequent synthesis of leukotrienes [37, 38] , did not affect the adhesive response to CMP 48/80 [13] . By contrast, WEB 2086, a PAF receptor antagonist, completely blocked the number of adherent leukocytes associated with CMP 48/80 superfusion of the rat mesentery (Fig. 2a) . The in vitro data confirmed the in vivo results; CMP 48/80-stimulated mast cells induced leukocyte adhesion to both endothelial cells and protein-coated plastic, an event inhibitable by WEB 2086 (Fig. 2b) . These data suggest that mast cell-derived PAF contributes significantly to subsequent neutrophil-endothelial cell adhesion, consistent with the fact that PAF is produced and released in significant quantities by mast cells. This is in part evidenced by the fact that the intestine synthesizes 70% less PAF in mast cell-deficient mice than in normal littermates [39] . Although these in vitro data do not exclude the possible contribution of endothelial-derived PAF to mast cell-induced adhesion in vivo, they do suggest that activated mast cells can indeed induce leukocyte adhesion through the release of this phospholipid.
Mast ceils induce leukocyte emigration
It is interesting to note that in our study with CMP 48/80 we saw only a subtle increase in leukocyte emigration at 30-60 min of CMP 48/80 superfusion [13] . The lack of emigration of adherent ceils may be related to the fact that the emigration may require longer periods of time than 60 min. Indeed, a leukocytic infiltrate was first noted at 60-120 min following injection of CMP 48/80 into the skin of mice and reached peak values only at 8 h. Alternatively. Raud et al. [15] There has been a tremendous amount of work completed on the adhesion molecules involved in the recruitment of leukocytes into postischemic vessels. Following the induction of ischemia/reperfusion in for example the cat mesentery. a very dramatic increase in neutrophil rolling. adhesion and ultimately neutrophil emigration into the tissue is observed ]40,41]. Using intravital microscopy, it was observed that the L-and P-selectin-binding carbohydrate, fucoidin, essentially abolished ( > 90%) leukocyte roiling in postischemic vessels [41] . Antibodies against either P-selectin (PB1.3) or L-selectin (DREG 200) reduced the number of rolling leukocytes by approx. 60% at both 10 and 60 min of reperfusion. Leukocyte rolling was not decreased further in animals given both anti-L-selectin and anti-P-selectin antibody; a 60% reduction in rolling was still observed. The tack of additive effect of tandem antibody therapy suggests either that P-selectin and Lselectin pathways worked in concert, i.e., as counterligands. or that they mediate different components of leukocyte roiling in a sequential manner so that one is dependent upon the other 1421. Moreover, based on the Land P-selectin antibody studies and the fucoidin study, these data may suggest that there exists an L-and P-selectin-independent fucoidin-inhibitable roiling pathway during reperfusion. Although each of the reagents was used at optimal concentrations it is also possible that fucoidin simply blocks P-selectin and L-selectin more effectively than the antibodies.
The third selectin, E-selectin, may also induce leukocyte rolling [43, 44] in inflamed vessels. However, it is unlikely that E-selectin plays a role in the first 60 min of reperfusion inasmuch as induction of this molecule on the surface of endothelium is thought to require at least 4 h of reperfusion. Moreover, only a very small number of vessels demonstrated E-selectin expression ( 15-200/c of all vessels) in postischemic coronary vasculature 1451. Finally, the leukocyte roiling in the feline intravimi microscopy study was abolished by fucoidin. yet fucoidin has been shown not to bind to E-seiectin [3, 46] . Fucoidin, a heavily sulfated poiysaccharide. may interfere with the ability of leukocytes to interact with other potential adhesive mechanisms. For example, fucoidin may compete for binding sites with sulfate-containing proteogiycans on the surface of vascular endothelium. Although the possibility that these molecules contribute to rolling is purely speculative. various other sulfated molecules have been shown to strongly interfere with leukocyte rolling in viva 147-491 and leukocyte adhesion in vitro [50] .
Acute treatment with a monocionai antibody (MoAb IB,), which immunoneutralized the P-subunit (CD181 of the CD I 1 /CD 18 adhesion giycoprotein complex, pre--vented reperfusion-induced increase in myeioperoxidase levels in numerous tissues. implicating a CD i g-dependent mechanism of neutrophil recruitment during l/R [5 i-531. Additionally, MoAb IB, completely prevented the reperfusion-induced increase in neutrophil adhesion as visualized by intravital microscopy [54] . These results suggested that the adhesion was entirely mediated by chr CD18 giycoprotein complex. Although neutrophii emigration was also completely prevented, whether the emigration was dependent on CD18 or simply on the inability of the neutrophiis to adequately adhere remains unclear. A clinically relevant observation is that administration of MoAB lB, at 60 min of reperfusion almost immediately reversed the adhesion of neutrophils to postcapillary venuies [55] . Clearly the neutrophii-endothelial ceil interaction could be interrupted. Similar results have been observed in the rat mcsentery and furthered by the availability of antibodies against other adhesion molecules [56] . Antibodies against either CD18 (MoAb CL26I. the CD1 1 b subunit of CD 1 I /CD 18 adhesion complex (MoAb 1 B6c) or against endnthelial ICAM-1 (MoAb lA29), a Ii&and for CD1 8. also significantly reduced reperfusion-induced neutrophii adhesion and emigration. The ICAM-I data were recently confirmed in the cat model of ischemia/reperfusion using the monoctonai antibody RR 1 / I [57] .
There is a growing body of evidence IO suggest that mast cells may be involved in the multi-step leukocyte recruitment associated with I/R. First. there is evidence to suggest that mast ceils become activated during ischemia/reperfusion. Boros et al.
[5X] have reported increased histamine release from the postischemic intestine. Although the cellular source of the histamine was not identified. mast ceils are a primary source of this pro-inflammatory mediator in the small bowel [7] . Although histamine is not thought to be a chemotactic molecule per se. it may participate in the recruitment of leukocytes by causing the expression of endothelial P-selectin [ 18. 2 I] . To the best of our knowledge, the role of anti-histamines on I/R-induced leukocyte recruitment has not been documented. Although histamine could be released by numerous other cells, only rat mucosal mast cells release a protease termed rat mast cell protease II (RMCPII). Increased plasma protease II levels (an index of mast cell degranulation) have been reported following intestinal I/R [59] . These data more specifically support the contention that mast cells degranulate in postischemic tissues. Recently, Kurose et al. [60] have visually assessed mast cell integrity at 30 min reperfusion of postischemic mesentery and noted a significant increase in degranulated mast cells that coincide closely with leukocyte adhesion. However, whether the mast cell degranulation was a cause or effect of I/R-induced leukocyte recruitment was unclear.
To directly address the issue of whether the degranulated mast cells contributed to leukocyte recruitment in I/R. mast cell stabilizers that prevented the rise in protease II levels were used. In animals pretreated with these reagents, a reduction in myeloperoxidase activity (index of neutrophil infiltration) was noted in the postischemic intestine [59] . To determine which phase of the leukocyte recruitment was affected by mast cells in I/R, intravital microscopy was performed and leukocyte rolling, adhesion and emigration were assessed in the cat postischemic mesenteric microvasculature [40] . Fig. 3 demonstrates that between I and 5 min of reperfusion, there was a very dramatic rise in leukocyte rolling which persisted for the next 60 min. In cromolyn pretreated animals, the flux of rolling leukocytes increased in the very early (5 min) reperfusion period but by 10 min the number of rolling leukocytes was significantly reduced, an event that persisted for the next 60 min. Cromolyn also reduced PMN adhesion by 50% but almost entirely inhibited leukocyte emigration out of postcapillary venules. These data suggest an important contribution of interstitial mast cells as mediators of the multi-step recruitment of PMNs from blood to postischemic tissues and raise the possibility that mast cells may set up a chemotactic gradient to draw leukocytes out of the vasculature.
If mast cell degranulation causes leukocyte infiltration into postischemic tissue, then some factor(s) must be activating the mast cells. The increased flux of oxidants previously described at the onset of reperfusion [61] may be responsible for mast cell activation inasmuch as superoxide is known to activate these cells [3l] . In order to test the hypothesis that oxidants are involved in I/R-induced mast cell degranulation, some animals were pretreated with superoxide dismutase and catalase [59] . This protocol prevented the release of protease II from mast cells and the subsequent leukocyte infiltration, suggesting that indeed superoxide and/or hydrogen peroxide were instrumental in mast cell degranulation. Although the source of the oxidants remains unknown, the fact that Boros et al. [62] demonstrated that allopurinol blocked by 87% the histamine release from postischemic gut suggests an important role for the oxidant-generating enzyme xanthine oxidase in I/R-induced mast cell activation.
Another mediator known to activate mast cells is anaphylatoxin (C3a and C5a). In fact in the heart it has been shown that anaphylatoxins cause histamine release from cardiac mast cells [63, 64] . Since C3a and C5a have been shown to play an important role in ischemia/reperfusion of the heart [65] , by inference it is tempting to speculate that these anaphylatoxins produced at the time of reperfusion can in addition to their direct effects on the vasculature also stimulate mast cells to release histamine and other pro-inflammatory mediators, thereby potentially contributing to leukocyte recruitment and reperfusion injury. Direct evidence to support this view is presently not available. Additionally, human mast cells release a number of neutral proteases including tryptase which have the capacity to generate C3a anaphylatoxin from human C3 in vitro [66] . This can conceivably function as an amplification system in numerous inflammatory conditions including ischemia/reperfusion.
Finally, Goldman et al. [67] have reported that mast cells may play a role in infiltration of neutrophils into the lung and subsequent pulmonary injury associated with remote (hind limb) I/R. Mast cell-deficient mice showed an attenuation of sequestered neutrophils and a reduction in lung edema in this model. Clearly, the role of mast cells may be far-reaching if products released from a postischemic site entered the systemic circulation and activated mast cells at a distant site where these cells caused distant organ injury. Alternatively. mast cells at the postischemic site could release factors (histamine, serotonin, cytokines. platelet-activating factor as well as proteases that generate anaphylatoxins) that would affect distant organs. Regardless of the site of activated mast cells, the importance of the observation that mast cell-deficient animals have reduced distant organ injury may be directly related to the pathogenesis of multiple organ failure.
I. I. IKE-mediated hypersensitiLi5 reactions
It is well established that mast cells are important cellular mediators of immediate hypersensitivity reactions and that they likely contribute significantly to the delayed recruitment of leukocytes during late phase reactions. The latter contention is based on experimental data that illustrate that challenge with anti-IgE caused a profound leukocytic influx into skin reaching maximal levels at 6-12 h after antigen challenge in normal mice [68] . This leukocyte infiltration, however, was virtually undetectable in genetically engineered, mast cell-deficient W/W " mice [68] . The leukocytic infiltrate observed at 6 h in normal mice challenged with anti-IgE could be reduced by approx. 50% with anti-TNF antiserum, suggesting that this cytokine contributes significantly to the delayed leukocyte infiltration in this allergen-induced mast cell degranulation system. Since IgE-dependent activation of human foreskin mast cells has been shown to induce the expression (at 6 h) of E-selectin 1691, an adhesion molecule on endothelial cells that induces leukocyte rolling [70] , a proposed scenario may be that IgE-dependent mast cell degranulation stimulates leukocyte-endothelial cell interactions via TNF and E-selectin.
To date leukocyte recruitment and the role of TNFcu. E-selectin or any of the other selectins has not been examined in late phase reactions using intravital video microscopy. primarily because of the difficulties with maintaining viable preparations for prolonged periods of time. However, numerous studies have recently been published using gene knockout mice exposed to various late phase reactions. The use of mutant mice lacking L-selectin has revealed reduced edema formation in delayed-type hypersensitivity reactions [7 1 I. Cellular infiltrates were not determined in these experiments. Although these data imply a role for L-selectin as a mediator of tissue dysfunction in mast cell-dependent models of inflammation, documentation of impaired leukocyte influx still awaits confirmation. In similar experiments, Subramaniam et al. [72] rcported that oxazolone sensitized animals challenged with oxazolone showed a significant mononuclear cell infiltrate at 24 h that was reduced by 53.8% in mutant mice lacking P-selectin. Interestingly, late phase responses were not inhibited in normal mice treated with a P-selectin antibody [73] . Meanwhile, mutant mice lacking E-selectin had no leukocytic impairment in late phase responses: however, addition of a P-selectin antibody significantly reduced neutrophil infiltrate in this model [73] . These data raise a role for selectins in the recruitment of leukocytes in delayed-type hypersensitivity reactions. However. it is likely that some redundancy in these chronic models may exist. i.e., leukocyte recruitment may be dependent upon more than one selectin. Whether mast cell-derived mediators contribute directly to inducing expression of endothelial selectins in these models is an important. :15 yet undetermined issue.
Bacterial toxins mediate leukocyte adhesion through mast cell activation
In the next section of this review. we will focus on two relatively new models of inflammation that may directly reflect human disease. In these models there is clear evidence that microcirculation and more specifically mast cell-induced leukocyte recruitment contribute to the pathology of bacterial toxin-induced tissue in.jur1
I. Helicohacter j?ylori toxins
In recent years. considerable attention has been devoted to the role of Helicobacter pylori in the pathogenesis of chronic gastritis and gastric ulceration. This microorganism, when ingested by human volunteers. produces gastritis, while eradication of H. pylori in ulcer patients leads to resolution of pathology. There is a growing body of evidence that links bacterial infection to infiltrating neutrophils in the gastric mucosa wherein the leukocytes cause tissue injury. This view is supported by reports demonstrating (1) a direct relationship between the extent of H. pylori-induced neutrophil infiltration and the severity of gastric mucosal injury. and (2) the t&r that H. pyhri promotes the adhesion of isolated humax] neutrophils to monolayers of human umbilical endothehai cells [74-761. The inflammatory potential of Ei. l$or! has also been demonstrated using intravital microscopic techniques to monitor leukocyte-endothelial cell adhesion in mcsenteric venules [77] . Exposure of rat mesentery to a water extract of H. pylori (HPE) leads to the recruitment of adherent leukocytes. which subsequently emigrate into the adjacent interstitial compartment. The HP&induced leukocyte adherence and emigration is accompanied by the formation of platelet-leukocyte aggregates, mast cell degranulation, and enhanced albumin leakage in mescnteric vcnules.
Comparable inflammatory responses were not elicited by exposure of the rat mesentery to a water extract of Escherichia coli.
The mast cell degranulation induced by HPE occurred as early as 10 min after exposure to the extract and could be largely prevented by prior treatment with ketotifen ( Table 3 ). The mast cell stabilizer had no effect on the HPE-induced recruitment of adherent leukocytes and platelet-leukocyte aggregation; however, it significantly attenuated the normally associated leukocyte emigration and albumin leakage responses. In addition, ketotifen treatment prevented the fall in venular shear rate that was usually elicited by HPE (Table 3 ). These observations indicate that the mast cell degranulation induced by HPE contributes significantly to the accompanying changes in venular hemodynamics, leukocyte emigration and albumin leakage but not the earlier event, leukocyte adhesion.
Clostridium difficile toxin A
The mast cell-derived substance that mediates the observed responses to HPE remains undefined; however, some evidence supports a potential role for platelet activating factor (PAF). The PAF receptor antagonist WEB 2086 appears to be as effective as ketotifen in blunting the HPE-induced alterations in leukocyte emigration, albumin leakage, and shear rate in rat mesenteric venules, while exerting no influence on the mast cell degranulation or leukocyte adherence responses caused by HPE (Table 3) . The observation that both ketotifen and WEB 2086 were effective in blunting albumin leakage within 10 min after HPE exposure, a time that was not associated with enhanced leukocyte adherence or emigration, suggests that a component of the albumin leakage response that is mediated by mast cell-derived PAF occurs independently of leukocyte recruitment.
Antibiotic therapy can be associated with the development of a chronic inflammatory condition affecting the colon (i.e., pseudomembranous colitis). The principal etiologic agent responsible for this iatrogenic form of enterocolitis is C. dificile, a Gram-negative anaerobic bacillus that produces two protein exotoxins: toxin A and toxin B. Animal studies have revealed that toxin A (TX-A) mediates the excess fluid secretion and inflammation associated with experimental C. diflcile enterocolitis. Mast cells have been implicated in the pathobiology of TX-A-induced mucosal dysfunction, with mast cell degranulation observed in gut mucosa within 15 min after TX-A exposure and an attenuation of leukocyte infiltration and tissue necrosis noted in animals pretreated with ketotifen [78, 79] .
Collectively, the responses elicited by HPE in the mesenteric microcirculation would suggest that toxins proExposure of rat mesentery to TX-A results in an increased adherence and emigration of leukocytes, plateletleukocyte aggregation, and enhanced albumin leakage in postcapillary venules and the degranulation of perivenular mast cells [80] . The recruitment of leukocytes elicited by TX-A appears to result from adhesive interactions mediated by P-selectin and ICAMon endothelial cells and CD1 1 /CD 18 on leukocytes, since monoclonal antibodies (MAbs) directed against these adhesion molecules markedly blunt TX-A-induced leukocyte adhesion. The P-selectin MAb also attenuated TX-A-induced plateletleukocyte aggregation. Sialyl-Lewis x (SLe"), a counterreceptor on leukocytes for P-selectin, is also effective in reducing TX-A-induced leukocyte adhesion to both endothelial cells and platelets. All of the reagents (MAbs and SLe") that reduced TX-A-induced leukocyte adhesion were also effective in blunting the enhanced albumin leakage normally elicited by the toxin. The leukocyte adhesion and albumin leakage caused by TX-A are affected by agents that either stabilize mast cells or interfere with histamine action. Lodoxamide, a mast cell stabilizer, effectively prevents the mast cell degranulation in mt mesentery that is elicited by TX-A exposure. A consequence of this treatment is an attenuation of leukocyte recruitment and a corresponding reduction in albumin leakage. Similar protective effects are noted following treatment with either diamine oxidase (histaminase) or an HI -receptor antagonist. The H ,-receptor antagonist was also effective in reducing the formation of platelet-leukocyte aggregates. These observations suggest that histamine represents an important mast cell-derived mediator of Tx-A-induced inflammation.
Overall, the reported observations concerning Tx-Amediated alterations in the mesenteric microvasculature are consistent with a mechanism wherein TX-A rapidly induces mast cell degranulation, leading to release and accumulation of histamine in the perivenular compartment. The mast cell-derived histamine appears to mediate at least part of the leukocyte-endothelial and platelet-leukocyte adhesion by engaging H,-receptors on endothelial cells and platelets, respectively, to increase the expression of Pselectin. Activation of the leukocyte adhesion glycoprotein CD1 1 /CD1 8 and its subsequent interaction with constitutively expressed ICAM-also contributes to the leukocyte recruitment elicited by C. djfJi:cile toxin A (Fig. 4) . 
Future directions
Regulating mast cell reactivity could conceivably become a viable approach to modulating feulcocyte influx and the inflammatory process. One potential (but certainly not exclusive) endogenous modulator of mast cell reactivity is nitric oxide (NO). Salvemini et al. 1811 reported that NO donors including nitroprusside decreased the amount of histamine released by mast cells. Moreover, this group demonstrated that L-NAME augmented the release of histamine from mast cells. Hogaboam et al. 1825 reported that NO inhibited PAF production from mast cells. Recent data from our laboratory [25] demonstrate that NO donors attenuate mast cell-dependent leukocyte recruitment in vivo and in vitro. CMP 48/80-induced leukocyte rolling and adhesion were almost entirely prevented by the NO donor. spermine-NO. Moreover, spermine-NO was as effective as WEB 2086 at preventing neutrophil adhesion in the in vitro assay system described in Fig. I b. An obvious direction is to begin to assess the role of NO in mast celi-mediated models of disease such as anapbytaxis, asthma and I/R. Indeed, recent work from Kurose et al. 1603 has demonstrated that three different NO donors inhibit I/Rinduced mast cell degranulation and the resultant leukocyte infiltration.
Finally. removal of endogenous NO activates mast ceils in vivo. Studies from our laboratory demonstrated that connective tissue mast cells located in close proximity to the mesenteric vasculature became activated following NO synthesis inhibition [31] . In another study mast cell-derived protease II levels from mucosal mast cells were shown to be elevated following systemic administration of L-NAME [83], suggesting that both connective tissue mast cells (from mesentery) and mucosal mast cells (intestinal mucosa) may be under physiologic control from the continuous release of endogenous NO. These results were extended by two groups; exposure of tissue to L-NAME caused detectable increase in oxidative stress within mast cells in vivo [84, 85] . Moreover, various mast cell stabilizers prevented the L-NAME-induced leukocyte recruitment suggesting that mast cells played an important role in leukocyte adhesion following NO synthesis inhibition ]3 11. Determining whether the reduction in NO production reported in ischemia/reperfusion, atherosclerosis and other pathologic states activates mast cells and thereby recruits leukocytes to affected sites is warranted and will be an important future direction.
